Combining pulsed radiofrequency and platelet-rich plasma for treating facial pain
Official title: Effectiveness and Safety of Platelet-Rich Plasma Combined With Pulsed Radiofrequency to Treat Patients With Infraorbital Neuralgia
Run by Beijing Tiantan Hospital · NCT06492213 · Data updated 2026-11-12
This study is testing whether combining a special type of injection with a new pain treatment can help people with stubborn facial pain who haven't found relief from other methods.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 240 (estimated) |
| Sponsor | Beijing Tiantan Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | July 1, 2024 |
| Main results expected | July 1, 2026 |
| Study ends | July 1, 2027 |
| Registry record updated | February 21, 2025 |
| Trial ID | NCT06492213 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 75 with severe infraorbital neuralgia who have not found relief from standard treatments.
✕Probably not a fit
Patients with certain blood disorders, severe organ dysfunction, or a history of destructive treatments may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter, prospective, observational study aims to evaluate the effectiveness and safety of combining platelet-rich plasma (PRP) injections with pulsed radiofrequency (PRF) treatment for patients suffering from refractory infraorbital neuralgia (IONa). The study focuses on individuals who have not responded well to conventional therapies and are seeking a minimally invasive treatment option. Participants will be assessed for pain relief and safety outcomes, with a particular emphasis on those reluctant to undergo more destructive therapies. The study employs a propensity score matching approach to ensure balanced comparisons between treatment groups.
Why it matters
Potential benefit: If successful, this approach could provide a new, effective, and minimally invasive treatment option for patients suffering from refractory infraorbital neuralgia.
How similar studies have gone: While the efficacy of pulsed radiofrequency has been previously established, the combination with platelet-rich plasma for this specific condition is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age between 18 to 75 years; 2. Paroxysmal or persistent stabbing pain in the distribution area of the infraorbital nerve and positive response to diagnostic block (1 ml of 2% lidocaine) prior to treatment; 3. NRS score≥7; 4. Scheduled for PRF treatment for IONa; 5. Signed informed consent. Exclusion Criteria: 1. Platelet count \<105\*109/L, ongoing anticoagulation therapy or antiplatelets treatment, coagulation disorders or bleeding disorders; 2. Severe cardiopulmonary or hepatorenal dysfunction; 3. Infection at the puncture site; . 4. Neuralgia secondary to tissue damage around the infraorbital foramen from causes such as maxillary sinusitis or tumor; 5. History of destructive treatments such as radiofrequency thermocoagulation, chemical ablation, infraorbital neurectomy, infraorbital nerve avulsion, etc; 6. History of mental disorders; 7. History of narcotic drug abuse; 8. Unable to cooperation.
Where it's running
-
Fang Luo
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Principal investigator: Luo Fang, M.D. — Beijing Tiantan Hospital
- Study coordinator: Lu Liu, M.D.
- Email: emmaliulu@163.com
- Phone: +8618618418228
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using a patient’s own fat mixed with platelet-rich fibrin to rebuild the breast after conservation surgery
Aiming to see if a patient’s own fat mixed with platelet-rich fibrin can help restore breast shape after breast-conserving cancer surgery.
-
Platelet-Rich Plasma from Two Different Systems in Knee Osteoarthritis
This study compares PRP made by two FDA-approved machines to see if the platelets differ and whether injections help knee symptoms.
-
PRP with fractional CO₂ laser to improve acne scars
This will test whether adding your own platelet-rich plasma (PRP) to fractional CO₂ laser treatment can improve moderate-to-severe acne scars in adults aged 18–40.
-
Using pulsed radiofrequency and platelet-rich plasma to treat glossopharyngeal neuralgia
This study is testing if combining pulsed radiofrequency treatment with platelet-rich plasma can help adults with glossopharyngeal neuralgia who haven't found relief from medications.
-
Combining microfracture surgery with platelet-rich plasma injection for ankle cartilage repair
This study is testing if adding a platelet-rich plasma injection to microfracture surgery can help people with ankle cartilage damage feel better and recover more effectively.
-
Combined PRP and hyaluronic acid injections for knee osteoarthritis
This study sees if giving a mix of platelet-rich plasma and hyaluronic acid into the knee helps people with osteoarthritis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.